期刊文献+

含缓释淀粉的肠内营养对重症急性胰腺炎病人预后的影响 被引量:1

The enteral nutrition containing slow release starch improves the outcome of severe acute pancreatitis patients
下载PDF
导出
摘要 目的:探讨含缓释淀粉的肠内营养对重症急性胰腺炎(SAP)病人的影响。方法:选择接受EN治疗的SAP病人180例,随机分为研究组和对照组,每组各90例,分别给予同等热量的EN支持,研究组用含缓释淀粉的瑞代,对照组用瑞素,观察EN支持前和支持后第10天病人空腹血糖(FBG)、餐后2 h血糖(2h BG)、糖化血红蛋白(HbA1c)的变化。并比较两组病人感染率、并发症发生率、住院时间和病死率的差异。结果:在营养支持后第10天,研究组病人FBG、2h BG、HbA1c水平均明显低于对照组(P<0.05)。研究组病人的感染率、并发症发生率明显低于对照组(P<0.05),住院时间亦明显短于对照组(P<0.05),病死率无显著性差异(P>0.05)。结论:含缓释淀粉的EN应用于SAP病人显著优于标准配方的EN制剂。 Objective: To evaluate the impacts of enteral nutrition contained with slow release starch in severe acute pancreatitis(SAP) patients. Methods: 180 cases of SAP patients were randomly divided into slow release starch group(Fresubin diabetes,SSPC,n=90) and control group(Fresubin,SSPC,n=90).The fasting blood glucose(FBG),2-hour postprandial blood glucose(2h BG) and glycosylated hemoglobin(HbA1c) were examined at base line and 10 days after nutrition support.The infectious rates,complication rates,mortality and hospital stay were compared between the two groups.Results: FBG,2h BG and HbA1c were significantly lower in slow release starch group than control group(P0.05)10 days after nutrition treatment.The infectious rate and complication rate were also significantly lower compared with control group(P0.05).The mortality rate was not significantly different between the two groups(P0.05),and the hospital stay in slow release starch group was shorter than control group(P0.05).Conclusion: Enteral nutrition contained with slow release starch is the preferred enteral nutrition in severe acute pancreatitis(SAP) patients.
作者 董朝晖
出处 《肠外与肠内营养》 CAS 北大核心 2011年第3期136-138,共3页 Parenteral & Enteral Nutrition
关键词 缓释淀粉 肠内营养 重症急性胰腺炎 Slow release starch Enteral nutrition Severe acute pancreatitis
  • 相关文献

参考文献8

二级参考文献21

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33004
  • 2McCargar LJ,Innis SM,Bowron E,et al.Effect of enteral nutritional products differing in carbohydrate and fat on indices of carbohydrate and liqid metabolism in patients with NIDDM[J].Mol Cell Biochem,1998,188(1-2):81-89.
  • 3Schrezenmeir J.Rationale for specialized nutrition support for hyperglycemic patients[J].Clin Nutr,1998,17 (Suppl 2):26-34.
  • 4Coulston AM.Clinical experience with modified enteral formulas for patients with diabetes[J].Clin Nutr,1998,17(Suppl 2):46-56.
  • 5Peters AL,Davidson MB,Isaac RM.Lack of glucose elevation after simulated tube feeding with a low-carbohydrate,high-fat enteral formula in patients with type I diabetes[J].Am J Med,1989,87(2):178-182.
  • 6Garg A,Bonanome A,Grundy SM,et al.Comparison of high-carbohydrate diet with a high-monunsaturated fat diet in patients with non-insulin-dependent diabetes mellitus[J].N Engl J Med,1988,319(13):829-834.
  • 7Bank S, Singh P, Pooran N, et al. Evaluation of factors that have reduced mortality from acute pancreatitis over the past 20 years. J Clin Gastroenterol, 2002,35:50-60.
  • 8Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically Ⅲ patients. N Engl J Med, 2001, 345:1359-1367.
  • 9Stürmer W, Kramer E, Kasper H, et al. Favourable glycaemic effects of a new balanced liquid diet for enteral nutrition-results of a short-term study in 30 type 2 diabetic patients [J]. Clin Nutrition, 1994, 13:221-227
  • 10Otto C, Sonnichsen AC, Ritter MM, et al. Influence of fiber, xylitol and fructose in enteral formulas on glucose and lipid metabolism in normal subjects [J]. Clin Invest,1993, 71:290-293

共引文献81

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部